Guinea-Bissau vs Tanzania: The number of people with susceptibility test result for rifampicin
Guinea-Bissau
89.04
in 2021
Tanzania
90.17
in 2021
Guinea-Bissau rank
70th
Tanzania rank
67th
The number of people with susceptibility test result for rifampicin over time
- Guinea-Bissau
- Tanzania
How they compare
Tanzania currently reports 90.17 against 89.04 in Guinea-Bissau, a difference of 1.13.
Across all 5 years both countries report, Tanzania has been ahead every year.
Guinea-Bissau ranks 70th and Tanzania ranks 67th of 146 countries.
Tanzania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.23 | 61.78 | 60.55 | Tanzania |
| 2020s | 73.23 | 77.55 | 4.32 | Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea-Bissau or Tanzania?
- Tanzania, at 90.17 against 89.04 in Guinea-Bissau as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea-Bissau and Tanzania?
- 1.13, with Tanzania ahead.
- How many years of comparable data are there for Guinea-Bissau and Tanzania?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea-Bissau and Tanzania rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea-Bissau ranks 70th and Tanzania ranks 67th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.